RELINT: FPH: Disclosure of Director & Officers Relevant Interests

3 Sep 2010 9:19 am

FPH 03/09/2010 RELINT

REL: 0918 HRS Fisher & Paykel Healthcare Corporation Limited

RELINT: FPH: Disclosure of Director & Officers Relevant Interests

Name of director or officer of public issuer: Michael Grenfell DANIELL Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Managing Director/Chief Executive Officer

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 200,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Michael Grenfell DANIELL

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse 4 1 September 2010 Consideration received from lapse 5 Not Applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not applicable Consideration received from disposal: 7 Not applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 9 September 2009

Name of director or officer of public issuer: Paul Nigel SHEARER Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Sales & Marketing

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 165,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Paul Nigel SHEARER

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 N/A Consideration received from disposal: 7 N/A

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 8 December 2009

Name of director or officer of public issuer: Lewis George GRADON Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Senior VP Products & Technology

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 165,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Lewis George GRADON

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 11 September 2009

Name of director or officer of public issuer: Antony George BARCLAY

Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Chief Financial Officer & Company Secretary

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 135,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Antony George BARCLAY

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not applicable Consideration received from disposal: 7 Not applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 8 December 2009

Name of director or officer of public issuer: Michael Robert BATTY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Group Operations Manager

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 80,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial interest Name of registered holder of securities 3 Michael Robert BATTY

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 10 June 2010

Name of director or officer of public issuer: Deborah Anne BAILEY Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President Human Resources

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 80,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Deborah Anne BAILEY

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not applicable Consideration paid for disposal: 7 Not applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 11 September 2009

Name of director or officer of public issuer: Neil Donald PRIME Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Former Vice President - Regulatory Affairs

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 60,000 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Neil Donald PRIME

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse 4 1 September 2010 Consideration paid for lapse 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 4 December 2009

Name of director or officer of public issuer: Winston FONG Name of public issuer: Fisher & Paykel Healthcare Corporation Limited Name of related body corporate (if applicable): Not Applicable Position held in public issuer: Vice President ICT

B Securities in public issuer or any related body corporate in which director or officer has relevant interest Number, class, and type of securities: 1 7,200 options to acquire ordinary shares

C Nature of relevant interest and name of registered holder Nature of relevant interest in securities: 2 Beneficial Ownership Name of registered holder of securities 3 Winston FONG

D Details of acquisitions and disposals If the relevant interest was acquired-- Date of lapse: 4 1 September 2010 Consideration paid for lapse: 5 Not applicable

If the relevant interest was disposed of-- Date of disposal: 6 Not Applicable Consideration paid for disposal: 7 Not Applicable

Type of transaction Describe the arrangement pursuant to which, or the circumstances in which, the lapse took place: 8 Lapse of options to acquire ordinary shares on expiry date of the 2005 issue under the 2003 option plan

E Total number of transactions this notice relates to: 9 One

F Date of last disclosure notice (whether in form 1 or form 2) by the director or officer: 10 11 September 2009 End CA:00199268 For:FPH Type:RELINT Time:2010-09-03:09:19:04

More announcements for FPH